JPMorgan downgrades Indian equities to 'neutral', cuts Nifty 50 target; Details here

JPMorgan downgrades Indian equities to ‘neutral’, cuts Nifty 50 target; Details here

Brokerage firm JPMorgan has downgraded Indian equities to “neutral” from its earlier rating of “overweight” and has also cut its price target on the Nifty 50 index across scenarios. In turn, JPMorgan has upgraded tech and Taiwan to “overweight” and raised its targets for the TAIEX index. JPMorgan’s downgrade comes just a day after HSBC…

Read More
Infosys cuts 8,440 jobs in Q4; targets 20,000 fresher hires in FY27

Infosys grants ₹52 crore stock award to Salil Parekh amid succession buzz

With the close of FY26, the top brass of India Inc are likely to be rewarded with stock options. Even though the subdued performance of several companies—especially those in the software sector—may weigh on the final payouts, the rewards remain sizeable. Infosys, the country’s second-largest IT services company, on Thursday (April 23) granted equities worth…

Read More
Chennai Petroleum Q4 Results: Net profit jumps 42%, revenue up 7%; dividend declared

Atul Auto shares jump 10% after MoU to supply 15,000 electric three-wheelers for nearly ₹500 crore

Shares of Atul Auto Ltd. gained nearly 10% on Friday, April 24, after the company said it has inked a memorandum of understanding (MoU) with Exponent Energy Pvt. Ltd. to manufacture and supply 15,000 electric three-wheelers integrated with the latter’s battery system and powertrain. The size of the contract is ₹490.5 crore with the Exponent…

Read More
Bernstein’s Letter to PM Modi lays out a plan for India’s 'high-'productivity' future; Details here

Bernstein’s Letter to PM Modi lays out a plan for India’s ‘high-‘productivity’ future; Details here

Brokerage firm Bernstein has written a letter to Prime Minister Narendra Modi where they talk about moving India from a low-end labor arbitrage to a high-productivity track. The firm highlighted important sectors on which they shed light on, adding that the traditional services engine of IT and BPOs, which supported 10-15 million people, supported consumption,…

Read More
Dr. Reddy's gets one step closer to Semaglutide approval in Canada but Goldman downgrades

Dr. Reddy’s gets one step closer to Semaglutide approval in Canada but Goldman downgrades

Dr. Reddy’s Laboratories Ltd. confirmed a CNBC-TV18 newsbreak on Friday, April 24, when it confirmed to the exchanges that it is still awaiting approval for its Semaglutide injection from the Canadian health regulator. “We wish to inform that the above captioned news item headline is correct, as the company has not yet received approval for…

Read More